Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment. Heather Quintana Suchan, a ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

Brazilian Society of Surgical Oncology: Realities and challenges of surgical oncologists in palliative care practice. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

There is a great need to streamline the process from the tissue sample to the diagnostic lab, whether it's genomic or immunohistochemistry, Robert Kratzke, MD, says. Delays in genomic testing continue ...

Vivek Subbiah, MD, considers artificial intelligence (AI) and comprehensive somatic and germline testing essential for guiding precision oncology and improving patient care. Vivek Subbiah, MD, chief ...

A $4.7 million collaboration led by the National Cancer Centre Singapore will develop a clinical-grade test using AI and ...

It’s the third most common cancer in the UK, causing tens of thousands of deaths annually. But what if the disease, often only diagnosed when it’s too late, could be stopped before it even begins?

NORFOLK, Va. — A new report from the American Lung Association shows that Virginia is making measurable progress in the fight against lung cancer, but the state still lags behind in early detection, ...

A new blood test will be offered to lung cancer patients in a move that NHS England says will benefit about 15,000 people each year. The test, known as a liquid biopsy, is designed to speed up access ...

New evidence from a Chinese cohort presented at the European Lung Cancer Congress (ELCC) 2026 shows that one-time low-dose ...